Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indre Offermann

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Emerging Drugs|October 27, 2006
Emerging drugs for age-related macular degenerationAlbert J Augustin, Indre Offermann
Drugs & Aging|November 21, 2007
Combination therapy for choroidal neovascularisationAlbert J Augustin, Indre Offermann
Retina (Philadelphia, Pa.)|February 10, 2007
Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasoneAlbert J Augustin, Stephan Puls, Indre Offermann
Klinische Monatsblatter Fur Augenheilkunde|November 1, 2002
[The significance of oxidative mechanisms in diseases of the retina]Albert J Augustin, H Burkhard Dick, Indre Offermann, et al.
Microbes and Infection|June 6, 2003
Prevalence and molecular diversity of pHS-2 plasmids, marker for arthritogenicity, among clinical Escherichia coli Shigella isolatesThomas Adam, Roland Siewerdt, Indre Offermann, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Emerging Drugs|October 27, 2006
Emerging drugs for age-related macular degenerationAlbert J Augustin, Indre Offermann
Drugs & Aging|November 21, 2007
Combination therapy for choroidal neovascularisationAlbert J Augustin, Indre Offermann
Retina (Philadelphia, Pa.)|February 10, 2007
Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasoneAlbert J Augustin, Stephan Puls, Indre Offermann
Klinische Monatsblatter Fur Augenheilkunde|November 1, 2002
[The significance of oxidative mechanisms in diseases of the retina]Albert J Augustin, H Burkhard Dick, Indre Offermann, et al.
Microbes and Infection|June 6, 2003
Prevalence and molecular diversity of pHS-2 plasmids, marker for arthritogenicity, among clinical Escherichia coli Shigella isolatesThomas Adam, Roland Siewerdt, Indre Offermann, et al.
Pageof 1